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ABSTRACT
Malignant peripheral nerve sheath tumor (MPNST) is a rare soft tissue sarcoma. This tumor included up to 10% of 1-2
of 100,000 population/year soft tissue sarcoma. This paper presents a MPNST case at superficial body, such as  frontal,
temporal and parietal head, neck, trunk, left arm, and visceral organs likes  brain,  lung, liver, right kidney, left
intraabdominal, and without associated with Neurofibromatosis type 1 (NF1) and no history of post radiation therapy.
Computed tomography (CT) scan of the brain was identified soft tissue mass at frontal and parietal sub cutanely,
hypodensity lesion at frontal obes that enhanced peripherally after contrast administration, suggestive malignancy.
Patient complained pain in nodule at his back. Chest roentgenogram and lung CT scan was founded multiple nodules.
There are also heterogeneous mass at left lobe of liver. Histological examination confirmed the diagnosis of MPNST.
This patient was planned for palliative treatment. 
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ABSTRAK 
Malignant peripheral nerve sheath tumor (MPNST) merupakan sarkoma jaringan lunak yang jarang. Tumor ini meliputi
MPNST sampai 10% dari 1-2 per 100.000 populasi/tahun kasus sarkoma jaringan lunak. Makalah ini memaparkan kasus
MPNST yang ditemukan di permukaan tubuh, yaitu kepala bagian frontal, temporal, parietal kanan, leher, lengan kiri,
torso, dan di organ-organ dalam yaitu otak, paru-paru, hepar, ginjal kanan, intraabdomen kiri, dan tanpa terkait dengan
neurofibromatosis tipe 1 (NF1) serta tanpa riwayat terapi radiasi. Pasien hanya mengeluh sakit pada benjolan di
punggung. Gambaran computed tomography (CT) otak ditemukan massa jaringan lunak di subkutis frontal dan parietal,
serta lesi hipodens di serebri frontal yang menyangat di perifer setelah pemberian kontras dicurigai ke arah keganasan.
Pada foto toraks dan CT paru ditemukan nodul multipel. Tampak pula massa pada ginjal kanan dan massa intrabdomen
kiri. Massa heterogen pada hepar lobus kiri ditemukan pada ultrasonografi abdomen. Pemeriksaan histologi
memastikan diagnosis MPNST. Pasien ini direncanakan untuk perawatan paliatif. 
Kata Kunci: Radiologi. MPNST, sarkoma
INTRODUCTION
We present a rare case of a patient with malignant peripheral nerve sheath tumor (MPNST)arising in multiple site of the body, from superficial body to visceral organ without known
the primary origins. In superficial body , masses located in the frontal, temporal and parietal
head, neck, trunk, left arm, and visceral organs likes  brain,  lung, left lobe liver, right kidney, left
intraabdominal. These highly aggressive tumors in the past literature are variously termed
malignant schwannoma, neurogenic sarcoma, and neurofibrosarcoma. The current term used
by the World Health Organization is MPNST because the originating cell is not clearly
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understood.1,2 MPNSTs may arise de novo, from
transformation plexiform neurofibromas and therefore
are strongly associated with neurofibromatosis type 1
(NF1) or von Recklinghausen’s disease, and associated
secondary to radiation therapy.2,3,4 The annual incidence
of soft tissue sarcomas is 1-2/100,000 population and
MPNSTs account for up to 10% from all soft tissue
sarcomas.1,2,5,6
CASE REPORT
The patient, a 38-year-old male, had complained
cough with white sputum for about one month. He felt
epigastric pain and dysphagia. No fever, dyspnea and
neurologic symptoms were found. Eight months prior to
admission, a nodule growth on frontal head with no pain.
Three months later nodules appear in other part of the
head, neck, trunk, and extremity (Fig. 1). He admitted
weight loss for 5 kilogram since the first nodule appeared.
He had done a resection of a tumor of his left thigh three
years previously in the local hospital without any further
information about histological examination of the
resected tumor. In physical examination, the nodules
were tender and immobile. The largest nodule measured
8 cm in diameter and located in the right frontal head.  No
other skin lesions could be identified beside those
multiple nodules. Chest examination found asymmetrical
chest, stem fremitus of the left lung are dull. Ronchi was
heard in both of the lung, respectively. 
From Laboratory finding, he had a white blood cell
count of 13.1 x 103/mm3, erythrocyte sedimentation rate
of 100 mm/hour, total protein level of 9.2 g/dL, albumin
level of 2.8 g/dL, globulin level of 6.4 g/dL, SGOT level of
70 U/L, SGPT level of 79 U/L, and urea level of 53 mg/dL. 
The chest radiograph (CXR) showed well-defined
multiple right lung nodules and left lower lung nodule.
(Fig. 2. A). Lateral CXR was identified the mass located at
posterior of the lung. Skull radiograph showed multiple
soft tissue masses at frontal and parietal area with small
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Fig. 1: Multiple soft tissue masses at frontal and parietal of the head (A), neck (B), abdomen (C), back (D), and left arm (E).
Fig. 2. A: CXR: well-defined multiple right lung nodules (red arrows) and
left lower mass (*). Fig. 2. B: from lateral CXR, the mass located at pos-
terior of the lung (M).
Fig. 4: Ultrasound: Hyperechoic round mass in the left liver lobe 
(red arrow).
Fig. 3: Skull radiograph: multiple soft tissue masses at the frontal and
parietal area (red arrow), with small litic lesion at the right frontal area
(yellow arrow).
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litic lesion at the right frontal bone area  (Fig. 3).
Ultrasound found hyperechoic round mass in the left liver
lobe (Fig. 4). Contrast enhanced CT of the chest at the
level of the carina showed right lobulated central mass
with heterogen density that attach to vertebral body and
left round peripheral mass and no interface with parietal
pleura. Lymphadenopaty in the para arcus aorta has
found (Fig. 5. A). In the Lung window, there are multiple
nodules and masses both of the lung (Fig. 5. B). Contras
enhanced CT at the level of kidney, there is a round solid
mass arise in the posterior of the right kidney and round
mass with low area density in the center at the anterior
tail of the pancreas (Fig. 6). Unenhanced CT of the brain
showed hypodensity lesion in the right parietal lobe and
multiple soft tissue masses at the right frontal and parietal
area (Fig.7. A). An enhanced CT of the brain show enhan-
cement of the lesion (Fig. 7. B). Bone window setting:
frontal bone destruction (Fig. 7. C). The histopathologic
diagnosis was high grade sarcoma, MPNST (Fig. 8).
Palliative treatment was planned for this patient. 
DISCUSSION
MPNSTs are locally very invasive malignant sarcomas,
multiple recurrences are frequent and eventual metastatic
spread.3 Ducatman et al. reported that multifocal
occurrence MPNST is rare, one of their study subject
developed a second primary MPNST after 30 months and
the other one after 13 years.4 MPNSTs arise from
neurofibromatosis 1 (NF1) between 40-60% and there is
4% chance of malignant transformation of NF1 after latent
periods of 10-20 years.1,2,7,8 Patients with NF1 is 4600
times greater for developing MPNST than general
population.1 There is 11% of MPNST follow to radiation
therapy with range 5-29 years latent periods.4,7 MPNSTs
impinge on young to middle-aged. The mean age patients
with NF1 are 28.7 years and without NF1 are 39.7 years,
respectively.4,7 Overall, the range age at diagnosis
between 20-50 years with an approximately equal sex
distribution.9 The origin cell of MPNSTs still not known,
Schwann cell is the most evidence than fibroblast or
perineural cells.7
Clinically, usually the peripheral nerve tumor do not
cause symptoms.7 Pain is the classic presenting
symptoms if any because of compression of intercostals
nerves or major airways.2,4,6,7 MPNSTs that are located in
the head and neck are rare, only 10% of all MPNSTs,
mostly are affected trunk and extremities.1,4,7 The most
common nerve affected is the sciatic nerve, followed by
brachial plexus and sacral plexus.1,2,9 Okada et al.
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Fig. 5. A: Mediastinal window: contrast enhanced CT of the chest at the level of the carina showed right lobulated central mass with heterogen density
that attach to thoracic vertebral body (red arrow) and left round peripheral mass and with no interface with parietal pleura (yellow arrow).
Lymphadenopathy in the para arcus aorta. Fig 5. B. Lung window: there are multiple nodules and masses in both of the lungs (red arrow head).
Fig. 6: Contras enhanced CT at the level of kidney, there is a round solid
mass arise in the posterior of the right kidney (red arrow) and round
mass with low area density in the center at the anterior tail of the
pancreas (arrow head).
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reported from their studied that 46 of 56 MPNSTs located
in deeper tissue.10 Sarcomas arise in the superficial
tissues they tend to be less aggressive compared than the
deep-seated tumor.7,9 Other signs of these tumor include
progressive enlargement, tumor size larger than 2-6 cm
(frequently exceeds 5 cm in diameter) with irregular
border, and increasing neurologic deficit.2,6,11 MPNSTs
that arise from NF1 should has NF1’s signs as seen in
table 1.2,9,12
In this case, there were no signs of NF1 and no history
of radiation therapy. The tumor resection at his left tight
had been done three years ago. Unfortunately, there was
no histological information about the tumor. The multiple
nodules growth in his body fit to the characteristic of
MPNST as already mentioned above. 
MPNSTs develop distant metastases including soft
tissue, lung, liver, pleura, bone, brain, abdominal cavity,
retroperitoneum, kidney, adrenal gland, diaphragm,
mediastinum, and ovaries.4,9,10,12 The lung is the most
common hematogenous metastatic spread.2 Intraneural
invasion through the nerve bundles is also common.7
Perineural spread is a metastatic type through the planes
of the neural sheath or along lymphatics of the epi-
neurium and perineurium.1,13,14,15
Radiography findings of MPNSTs usually normal or
non specific soft tissue mass.9 Usually screening CXR
are discovered this tumor.7 A sharp border, round,
elliptical, or lobulated mass may be seen on plain
radiograph.7 In rare cases there are a fusiform mass with
surrounding fat, calcification and bone involvement.7,9 At
angiography, characteristic of neurogenic neoplasms is
recognition of corkscrew-type vessels at the upper or
lower pool of the tumor, which is manifestation
hypertrophy of nutrient nerve vasculature. Also there is
displacement of major vascular structures because the
site of the origin lesion inside the neurovascular bundle.9
Bone scintigraphy of MPNSTs are not specific.9 Gallium-67
is very helpful for distinguish MPNST from benign lesion.
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Fig. 8. A: Fine Needle Aspiration Biopsy (FNAB) from left arm nodule, tumor cell with characteristic pleomorphic core in hyperchromatic spindle cell.
Fig. 8. B. Trans Thoracal Needle Aspiration (TTNA) found malignancy cell with characteristic pleomorphic core in hyperchromatic round and partly
spindle cell. Fig. 8. C. Histopathology from nodule in the head: pleomorphic core in hyperchromatic spindle cell, mitotic activity was founded in the fib-
riler and myxoid stroma. 
Fig. 7. A: Un enhanced CT of the brain showed hypodens lesion in the right parietal lobe (red arrow head) and multiple soft tissue masses at the right
frontal and parietal area (yellow arrow). Fig.7.B. Enhanced CT of the brain show enhancement of the lesion red arrow and yellow arrow). Fig.7. C. Bone
window setting: frontal bone destruction (white arrow). 
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Gallium-67 imaging has shown that MPNSTs have
greater uptake compared with benign lesions.2,8,9,12
Used of 18-fluorodeoxyglucose positron emission
tomography (18-FDG PET) to identification MPNSTs have
been reported. MPNST will increase uptake of 18-FDG but
some benign plexiform neurofibroma also showed the
same activity.12 MPNSTs can be detecting by either CT or
MRI although some medical literature reported MRI is
superior to CT.1,9 Several imaging characteristics are
listed in table 3.9
At CT, the most characteristic feature of malignancy is
round or linear low-density areas in central or peripheral
within higher density mass after contrast administration.
The low-density area is due to hemorrhage and
necrosis.6,16 Other imaging features of MPNSTs are
irregular and infiltrative of tumor border; bone
destruction with irregular margins.8 A sudden increase in
size or development of heterogeneous attenuation at CT
should be suggestive of malignant degeneration of a
benign neurogenic tumor to MPNST.16,17 MPNSTs are
usually of variable signal intensity on T1WI and T2WI
magnetic resonance imaging (MRI).5,17 Nerve sheath
tumors have slightly greater signal intensity than muscle
on T1WI and markedly increased signal intensity than fat
on T2WI or contrast-enhanced images.7,9 The path-
hognomonic sign of neurogenic tumor is seen as fusiform
shape with the nerve entering and exiting mass. In small
nerves or those in the subcutaneous and retroperi-
toneum, these sign is not always seen.5 On T2WI MRI, a
central hypointensity surrounded by peripheral
hyperintensity is called target sign and mostly benign
characteristic.5,17,18 Target appearance caused by the
more vascular fibrous tissue seen centrally and less
cellular and vascular myxoid tissue peripherally.2 Target
sign can be seen on CT not well as MRI.7.9,18 Multiple
small ring-like structures with peripheral higher signal
intensity on T2WI or proton density MRI occasionally
(fascicular sign) can be seen in MRI.5,9
In this case, radiology appearances lead to
malignancy without any information type of the tumor.
Patient has founded multifocal mass with multiple lung
mass and nodules  that identified at the beginning of the
case. This patient was not examined under MRI,
angiography and Gallium-67 scintigraphy because those
modalities are not provided in our hospital. The patient’s
skull radiograph showed the multiple soft tissue masses.
CXR clearly, described multiple nodules in both over the
lung. CT of the chest showed one mass that attach to
thoracic vertebral body at the level of carina is suspected
origin from spinal nerve. There was no neurologic deficit
though there is metastatic mass in his parietal lobe of the
brain.  
MPNST grow inside the nerve sheath, adopting a
spindle or globular appearance, and though most of them
present fusiform, a shape caused by nerve roots entering
and exiting the nerve.1,9 Microscopically, MPNSTs are
usually more hypercellular with hyperchromatic spindle
cell proliferation, irregular and pleomorphism nuclei, cyst
formation, and mitotic activity.2,7,19 Immunohistoche-
mical demonstrate focal S-100 protein positivity (50%-
90%), though 30% may be negative.1,2,3 These tumors
may reactivity for Leu-7 or myelin basic protein, but they
are negative for cytokeratins. Occassionally, they are
positive for the melanocytic marker HMB-45.1 This patient
have FNAB from nodule of the left arm, TTNA, and biopsy
examination from nodule of the head. All of this
examination positively diagnosed MPNST. Very
aggressive multifocal MPNSTs possibly happened in this
case. Yet, in this patient we cannot confirm the primary of
the tumor.
First choice of treatment is surgical; with wide en
bloc resection.1,2,7 Local recurrence rate different
between 40-68%.2,7 Postoperative radiations and
chemotherapy has benefit to reduce local recurrence
significantly.1,7 In contrast, most reports emphasize that
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Six or more 
Greater than 5 mm in greatest diameter in prepubertal patients
Greater than 15 mm in greatest diameter in postpubertal patients
Two or more neurofibromas (any type) or one plexiform neurofibromas
Axilary or inguinal freckling
Optic glioma
Two or more Lisch nodules (i.e., iris hamartomas)
Distinctive osseous lesions (e.g., sphenoid dysplasia, pseudoarthrosis)
First-degree relative with NF1, as diagnosed by above criteria
*Two or more of these criteria are required for diagnosis.
Source: Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. 
Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic
correlation.9
Table 1: Criteria of NF1*
Table 2: Imaging Signs of Neurogenic Neoplasms
Sign Modality Depicting the Sign 
Fusiform MR (less well seen with CT, US)
Entering and exiting nerve MR (less well seen with CT, US)
Low attenuation Unenhanced CT
Target sign T2-weighted MR (less well seen with CT)
Fascicular sign T2-and proton density-weighted MR
Split-fat sign T1-weighted MR (less well seen with CT)
Associated muscle atrophy T1-weighted MR  
Source: Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. 
Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic
correlation.9
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radiation and chemotherapy not effective in the treatment
of MPNSTs.7,19,20 Palliative treatment was planned for this
patient. 
Patients with and without NF1 have 10%-16% and
50%-53% five years survival rate, respectively.1,2,7,12
Factors that influence prognosis of patient are patient’s
age (age > 30 yo has better prognosis), tumor location,
size (tumor < 10  cm in diameter has better prognosis),
histological subtype, tumor grade, molecular genetics,
completeness of resection, recurrence, metastasis, and
presence of NF1.1,7 Okada et al. reported only large
tumor size and metastatic at presentation were
independent prognostic factors.10 High histological grade
were related with poor prognostic although an
independency of histological grade of MPNST still
obscure.10
CONCLUSION
This is a rare case  of MPNST in Indonesia with
multifocal mass which was not associated of NF1 and no
history of  radiation therapy. In this case the primary
origins of the tumor difficult to explained because patient
has came with respiratory complain and swelling in the
head, with history of tumor resection in the left tigh 3
years before without histological information of the
tumor.  This soft tissue sarcoma is not always symptomatic
especially in early stage. The diagnosis of this case have
been made based on clinical finding, CXR, chest CT, head
CT and ultrasound of the abdomen and proven by
histological examination. v
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